Last Updated on October 11, 2024 by The Health Master
USFDA approval
Indian pharmaceutical giant, Alembic Pharmaceuticals, has announced a significant milestone in its US market expansion. The company has received final USFDA approval from the stringent US Food and Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Fluphenazine Hydrochloride Tablets.
This green light paves the way for Alembic to introduce generic versions of Prolixin Tablets in strengths of 1 mg, 2.5 mg, 5 mg, and 10 mg into the US market.
Fluphenazine Hydrochloride: A Key Treatment Option
Fluphenazine hydrochloride is a widely prescribed medication used in managing the symptoms of psychotic disorders.
Its therapeutic equivalence to the reference listed drug, Prolixin, manufactured by Apothecon, has been established through rigorous evaluation by the USFDA.
Alembic’s Strong US Footprint
This latest USFDA approval solidifies Alembic’s position as a leading player in the US generic pharmaceutical market.
With a cumulative tally of 210 ANDA approvals, including 182 final USFDA approvals and 28 tentative USFDA approvals, the company has demonstrated a consistent track record of success in gaining regulatory clearances.
Key Takeaways:
- Alembic Pharmaceuticals has received USFDA approval for generic Fluphenazine Hydrochloride Tablets.
- The drug will be available in strengths of 1 mg, 2.5 mg, 5 mg, and 10 mg.
- Fluphenazine hydrochloride is indicated for managing psychotic disorders.
- Alembic now has a total of 210 ANDA approvals from the USFDA.
This latest achievement underscores Alembic’s commitment to providing high-quality, affordable generic medications to patients in the United States.
As the company continues to expand its product portfolio, it is poised to make a substantial impact on healthcare accessibility and affordability.
Disclaimer: This article contains information derived from the source mentioned below. Our team utilized an AI language model to rewrite and present the news or article in a unique format.
USFDA approval granted for Topiramate Capsules USP
USFDA approval granted for the drug used for Colon Cleansing
USFDA approval granted for the drug for the treatment of Migraine
USFDA approval granted for this chronic heart failure treatment drug
USFDA approval granted for generic Bromfenac Ophthalmic Solution
USFDA approval granted for this BP lowering drug
War on Drugs: Anti-Narcotics Task Force on the Way
Schedule M: Over 100 Pharma MSMEs in Telangana on the Brink of Closure
CDSCO Panel approval granted for Clinical Trial On Linaclotide Capsules
Budget 2024: Mixed Bag for Indian Pharma Industry
Drug alert: 61 drug samples declared as NSQ in June 2024
Fire breaks out at Pharma Plant in Maharashtra
Drug recall: Sanofi recalls Allegra, Combiflam suspensions due to this reason
Simple Urine Test a Lifesaver: Especially for Diabetics and High BP
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
